SEC-sourced researchBeta
CNBX
CNBX Pharmaceuticals Inc.
Company comparison ↗
Data passport
- CIK
- 0001343009
- Exchange
- OTC
- Business activity
- — · SIC 2834
- Financial inputs
- 5/6
- Filing date
- Oct 1, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| August 2024 | 130,074.0000 | Dec 1, 2025 |
| August 2025 | 0.0000 | Dec 1, 2025 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| August 2025 | 0.0000 | -313,976.0000 | -171,305.0000 | 18,437.0000 | — | Dec 1, 2025 |
| August 2024 | 130,074.0000 | -695,198.0000 | -244,269.0000 | 31,383.0000 | — | Dec 1, 2025 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $0 | August 2025 | Dec 1, 2025 | 10-K |
| Previous period revenueRevenues | $130.07K | August 2024 | Dec 1, 2025 | 10-K |
| Net incomeNetIncomeLoss | -$313.98K | August 2025 | Dec 1, 2025 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$171.31K | August 2025 | Dec 1, 2025 | 10-K |
| Total assetsAssets | $18.44K | August 2025 | Dec 1, 2025 | 10-K |
| Total liabilities | — | — | — | — |